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Abstract
The present article aims to assess the innovative activity in the Brazilian most representative sector in biotechnology 
field. The search was conducted through patent applications of residents at the National Institute of Industrial Property 
(INPI - Brazil), from 2000 to 2010. This article will also examine the patent applicants’ profile and the partnerships among 
academic institutions and private firms in Brazil. The website of European Patent Office (EPO) patent database - Espacenet 
was used to conduct the survey, and the search strategy fields selected for the patent applications were: (i) Priority 
Number: BR (Brazil), and (ii)  the International Patent Classification (IPC)  - C12N, C07K14, and C07H21/04. The patent 
applications by Brazilian residents, from 2000 to 2010 in the Espacenet for the classifications adopted indicates a total of 
396 patent applications in the most representative sectors in biotechnology over the past 10 years. After the Brazilian 
Innovation Law there is a growth trend line particularly in the years 2007 and 2008. The universities hold 48% of the patent 
applications in biotechnology, following by Individuals/ Researchers with 20%, Public Research Centers and Private Firms 
with 15%, and 11% of the total, respectively.
Keywords: Patents; innovation; biotechnology; university, intellectual property, and Brazil.
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Introduction
Economic globalization forced countries to seek for com-
petitiveness by promoting technological innovation. Several 
governments have been eager to facilitate the consolidation 
of national firms at the same time that they establish incen-
tives and favorable conditions to attract foreign investment. 
In 2004, Brazil launched the Brazilian Innovation Law aiming 
at strengthening the transfer of knowledge from academic 
environment to the private sector. This law has impacted 
the management of knowledge in many sectors, especially 
in those where science is closer to technology, for instance, 
Information and Communication Technology (ICTs) and Bi-
otechnology, therefore has foster partnership for innovation 
and patent applications.
Innovation has been defined by Lundvall (2005) as a process 
that involves the discontinuity of technical features in the use 
of a product or process, and the introduction, diffusion and 
adaptation of a new technology. The author points out that 
it is important to distinguish the concept of innovation and 
the concept of invention. Invention is the creation of some-
thing new that can be disclosed by scientific papers, patents, 
prototypes, even if it still does not have a commercial appli-
cation. Innovation is the invention that hits the market. The 
author puts emphasis on the existence of empirical studies 
showing that the key to the transformation of technological 
innovation into economic results would be the training and 
capacity building in human resources.
Evaluating around 2,000 significant technological innovations 
in Britain from 1945 to 1979, Pavitt (1990) proposes a tax-
onomy of sectorial  technological innovation patterns and 
establishes three patterns groups with distinct technological 
paths: (i) “suppliers dominated firms”: they are in traditional 
sectors such as agriculture, civil construction and equipment 
industry whose technological path is defined by cost reduc-
tion; (ii) “production intensive firms”: they are based on 
large-scale fabrication and assembly production. The firms 
produce for price-sensitive consumers. This group com-
prises food products, metal manufacturing, shipbuilding, mo-
tor vehicles, and glass and cement; and (iii) “science-based 
firms”: in this case, the main sources of technology are the 
R&D activities, based on the development of the underlying 
sciences in the universities. They are in the chemical and the 
electronic/electrical sectors. Although the author does not 
refer to biotechnology since in the surveyed period there 
was no industry characterized as such, modern biotechnol-
ogy is currently acknowledged as science-based industry. 
A study conducted by Rapini (2007) states that sectors such 
as genetic engineering, organic and inorganic chemistry, food 
technology, biotechnology, laser technology and microelec-
tronics (telecommunications, electronic components, data 
processing), mainly characterized for being science-based, 
are more prone to the University-Enterprise interaction.
These authors understand the importance of the protection 
mechanisms of intellectual property (IP), with emphasis on 
patent mechanism, to secure the investments made in the in-
novative process, mainly in Research & Development (R&D) 
activities. For Pavitt (op. cit.), patent protection is especially 
important to the science-based industries in view of the high 
investments in R&D as the patents ensure the temporary- 
exclusive right to exploitation of innovation allowing the in-
vestment return to their inventors. Modern biotechnology 
is basic knowledge-intensive field, requiring a great deal of 
basic research and a long development process for creating 
a new product. The cost to bring the product to market is 
high, thus there is a claim for IP Rights. 
From the 1980s, the so-called “modern biotechnology” de-
fined as the use of biological processes, living organisms or 
their parts (tissues and cells) for generation of products 
or industrial process, with large-scale industrial applica-
tion of scientific and technological advances. The innovation 
in products and process is the result of biological science 
research development.
In the last few years, many relevant events have happened 
in the field of biotechnology. Figure 1 is an incomplete 
attempt to show a list of  those events in the history of 
modern biotechnology.
Biotechnology industries has played a special role in techno-
logical innovation in many countries,  particularly those who 
are on the technological frontier. But  developing countries 
also are very concerned about this. Besides de Innovation 
Law, Brazil has invested in human resources qualification, 
and has launched several postgraduate courses at universi-
ties, including biotechnology area. Until 2011 there were 30 
postgraduate courses in biotechnology in Brazil. 
One important aspect to evaluate the performance of the 
country in innovation is the number of patent applications, as 
well as investments in R&D. These indicators have been used 
as an indicator of technological innovation development and 
of the of firms, regions and countries. The number of pat-
ent applications can reflect its technological dynamism and 
the information contained in the patent document  can give 
some indications on the direction of technological changes.
Jannuzi and Souza (2008) shows an increase, 150 percent, 
in patent applications by Brazilian universities at the United 
States Patent and Marks Office (USPTO), from 88 patent 
applications in 1990, to 220 in 2000. Póvoa (2006) analyzed 
de patent application by Brazilian universities at National 
Institute of Industrial Property (INPI), for 25 years (1979 
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The present article aims to assess the innovative activity 
in the most representative areas in biotechnology through 
patent applications of residents at the National Institute of 
Industrial Property (INPI - Brazil), from 2000 to 2010. At 
first it presents a short overview of innovation in Brazil. 
Then there is a description of the search methodology pro-
cess and strategy. And finally the article presents the main 
findings, by examining the patent applicants’ profile and the 
tendencies of partnerships among academic institutions and 
private firms in this field in the Brazilian context, as well.
to 2004), and has shown that  47,2 percent of them were 
applied in the last 3 years (2002, 2003,and 2004). Other 
studies has showed the same significant increase in patent 
application at large, and in particularly at universities (Gul-
lo, et al., 2011; Oliveira and Velho, 2009; Souza, et al., 2011; 
Vasconcellos, 2003). 
Furthermore, Querido, et al. (2011) has surveyed both, pat-
ent application and patent granted at Brazilian universities. 
These authors have created a Index of Patents Granting to 
reflect de university efficiency in innovation process.
Figure 1 - Chronology of some relevant events in biotechnology
Year Event
1971 Escherichia coli recombinant DNA (USA)
1972 Chakrabarty patent application (USA)
1973 Recombinant DNA technology discovered in the USA
1974 Embrapa creates Cenargen (National Center for  
Genetic Resources) (Brazil)
1976 1st biotech company in the world - Genentech (USA)
1978 DNA segment responsible for insulin was isolated and inserted into E. Coli Bacterium (USA)
1980 Interferon is produced with recombinant DNA technology (USA)
1981 Chakrabarty patent was granted (USA)
1982 USA approve the use of recombinant insulin
1982 National Program of Biotechnology in Brazil is launched ( PRONAB/CNPq)
1986 Creation of the Brazilian Association of Biotech Enterprises (ABRAPI) with 8 enterprises
1987 HR Training Program for Strategic Activities (RHAE) at MCT/ Brazil
1990 1765 patent applications at USPTO (USA)
1990  32 patent applications at INPI (Brazil)
1990 The beginning of the Human Genome Project (HGP) in the USA
1994 Trade Related Intellectual Property Aspects Agreement (TRIPS) launched by OMC
1996  The Brazilian IP Law launched
1997 Beginning of the sequencing of the bacterium Xylella fastidiosa (FAPESP / Brazil)
2000 Completion of HGP in the USA (1st phase – “DNA draft”)
2000 Biotechnology and Genetic Resources Project -  Genome Brazil /  29 patent applications (TECPAR / 
Brazil)
2001 4284 biotech companies worldwide and US$ 35 billion revenue;
in Brazil – 304 biotechnology-based companies
2001 Creation of  Biotechnology Sectoral Fund (FINEP / Brazil)
2002 7763 patent applications at USPTO
2003 The final mapping of the human genome (USA)
2005  Brazillian Innovation Law is launched
2012 30 postgraduate programs in Biotechnology  (Brazil)
2013  U.S. Supreme Court ruled that human genes can not be patented
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objectives, the one to strengthen a culture of innovation, and 
intellectual property in the context of science and technol-
ogy institutions that has launched the Centers for Techno-
logical Innovation (Núcleos de Inovação Tecnológica – NITs) 
at the universities and public research centers. 
There is already a process of improving the regulatory 
framework for innovation. The proposed Amendment to the 
Constitution – “Innovation PEC”, as it became known, for 
example formalizes the National System of Science, Tech-
nology and Innovation, which will coordinate the actions of 
public and private entities and foster collaboration by allow-
ing sharing of human resources and equipment. Also, there 
is Law Project 2.177/2011, which provides the preparation 
of the National Code of Science, Technology and Innovation. 
Among the points of the new law, are creating research co-
operative environments, and flexible exclusive dedication of 
researchers linked to public institutions.
In this context, national and international regulatory frame-
work have been stimulating stronger competitiveness 
among countries. Hence, they exert pressure to transform 
research into innovation. In addition, in the international 
level, the TRIPS Agreement  has introduced a new standard 
for protection of IP Rights. In the knowledge-based econ-
omy, the ability to generate and diffuse innovations has a 
direct relationship with levels of productivity and competi-
tiveness achieved by countries. This context has required a 
new field of knowledge to understand what intangible assets 
are, and its economic importance. In this sense, this sce-
nario has showed how relevant is to study the innovation 
process at the universities and how they are appropriat-
ing the knowledge generated in their research centers in 
biotechnology field.  
The survey on Biotechnology Patent Applications: 
Methodology
The website of EPO patent data base Espacenet were used 
to conduct the survey on patent applications. According to 
the website, it offers free access to more than 70 million 
patent documents worldwide, containing information about 
inventions and technical developments from 1836 to today .
The Espacenet database provides information about patent 
applications of more than 90 countries and is characterized 
as a fairly complete and updated public database with more 
search options available. In addition it has free access and a 
friendly interface. 
The search strategy used, i.e. the search fields selected at 
Worldwide Collection of Published Applications    (http://
worldwide.espacenet.com/advancedSearch?locale=en_EP), 
in item “Advanced Search”, were:
The Innovation in Brazil: a brief overview
In 2010, a daily Brazilian newspaper published a reportage 
announced a very important achievement: Brazil rose four 
positions in the world ranking and became the 13th big-
gest science producer in the world, with 26,482 scientific 
articles published in indexed journals in 2008, according to a 
UNESCO Report. Despite the evolution of the research, the 
reportage signals problems in transforming research con-
ducted in universities into innovation in firms, as it is shown 
by the low number of patent applications in the country. 
Thus, Brazil is quite good in R&D investments, but is not 
able to transform these investments into technological in-
novations. Moreover, 80% of the country’s scientists and en-
gineers are in the universities or research centers which are 
almost always public institutions, while in the United States 
(USA) 80% of the engineers are in the private firms. (Cruz 
and Pacheco, 2004).
For the Brazilian Minister of Science, Technology and Innova-
tion, what is currently lacking is a bridge to connect univer-
sities to private sector, since “we occupy relevant places in 
the world scientific production (...). Of the overall published 
scientific articles 2.5% are produced by Brazilians” (Agência 
Gestão C,T&I, 2012). According to the Minister, very few 
sectors have achieved a good technology and innovation 
development in Brazil. Aeronautics, oil and agriculture were 
the sectors that had participation from research, develop-
ment and innovation institutions, accordingo to him.
The number of patent applications has been used as an indi-
cator of technological development. According to the Oslo 
Manual (1997), the number of patents of a particular compa-
ny or country can reflect its technological dynamism. How-
ever, the Oslo Manual also identifies problems related to the 
use of patents as indicators, “because many innovations do 
not correspond to patented inventions; many patents were 
inventions of technological and economic value almost ir-
relevant; although many of them have quite expressive value, 
many others will never result in innovation. “ (op.cit., p. 27)
Still, patent applications continues to be used as an indicator 
of innovation. Therefore the analysis of the European Pat-
ent Office (EPO) Patent Database – Espacenet, that is used 
in this search, makes it possible to identify the situation of 
patent application in biotechnology in recent years in Brazil.
Futhermore, the Brazilian Innovation Law launched in 2004, 
and implemented in 2005 plays a relevant role in the pro-
motion of innovation and scientific-technological research. 
It aims to foster the interaction between the private sec-
tor and the academic institutions to strengthen the com-
petitiveness of the national industrial sector. In this regard, 
it provides innovation incentives and has between others 
94
ISSN: 0718-2724. (http://www.jotmi.org) 
Journal of Technology Management & Innovation © Universidad Alberto Hurtado, Facultad de Economía y Negocios.
J. Technol. Manag. Innov. 2013, Volume 8, Issue 4
be classified as C12N, but if only the temperature system 
is modified, the patent applications shall not be considered. 
With this delimitation  we aim to identify only those patent 
applications that develop new biotechnological technolo-
gies. Therefore, conventional vaccines, for example, will not 
be computed, but the recombinant will. New varieties of 
plants will be left out if classic improvement was used since 
this type of improvement does not enter modern biotech-
nology. In the same way, if genetic engineering was used in 
production process it will be included in one of the three 
classifications applied.
Even  the Organisation for Economic Co-Operation and 
Development (OECD, 2005, p.5) presented a report “to 
outline a statistical framework to guide the measurement of 
biotechnology activity” that  shows 30 IPC codes for provi-
sional definition of biotechnology patents. However, it indi-
cates that 55.5% of EPO biotechnology patent applications 
was attributable to C12N alone.
So to better define the classifications to be used in a patent 
search, one must take into account the objective delimita-
tion of what is sought, effectively. This particular study  works 
with the data on modern biotechnology defined previously 
in this article.  These three IPC codes, C12N, C07K14, and 
C07K21/04, will allow a comprehensive search in modern 
biotechnology most representatives sectors. 
After the search strategy definition, all summaries of the 
patent applications in those IPC codes were ordered by year. 
From this material, it was possible to draw up a summary 
table for each year, containing the patent applicant, the ab-
stract of the patent applications, and the patent applicants’ 
profile. This reference framework made it possible to iden-
tify repetitions, and incomplete or incorrect data that were 
checked in the complete document for each patent applica-
tions. Data tabulation was performed taking into account 
the following variables:
• Number of patent applications per year;
• Number of patent applications by applicants’ pro-
file (universities, individuals, research centers, private com-
panies and partnerships);
• Percentage of participation by applicant profile; and
• Historical series from year 2000 to 2010.
The survey on Biotechnology Patent Applications: 
Main Results
      
The assessment of the main results of the survey conducted 
on the patent applications by Brazilian residents, from 2000 
• Priority Number: “BR” (Brazil) “AND” Year (the 
years were enter one by one from 2000 to 2010); and
• IPC (International Patent Classification): “C12N”, 
“C07K14” and “C07H21/04” (one by one).
Thus, the three classifications adopted cover the most cur-
rent information in representatives areas of  biotechnology. 
They are defined as follow:
• C12N – Microorganisms or enzymes; and their 
composition (biocides, pest repellents or attractants, or 
plant growth regulators containing microorganisms, viruses, 
microbial fungi, enzymes, fermented, or substances produced 
by, or extracted from, micro-organisms or animal material); 
• C07K14 – Peptides having more than 20 amino 
acids; Gastrins; Somatostatins; Melanotropins (Melanocyte-
stimulating hormone); Derivatives thereof: This subclass will 
contain patents in proteomics (any patented protein);
• C07H21/04 – Compounds containing two or 
more mononucleotide measures, having separate phos-
phate or polyphosphate groups, linked by saccharide radi-
cals of nucleoside groups, e.g., nucleic acids with deoxyri-
bozyme as radical saccharide: DNA patents. They contain 
the overall genomics.  
The International Patent Classification (IPC)  was imple-
mented after the Strasbourg Agreement, and entered into 
force in 1975. It is a global index for the broader technologi-
cal fields, and establishes a single and international classifica-
tion for patents. Today over 100 countries use this classifica-
tion, including Brazil. The IPC has been periodically revised in 
order to improve the system and to take account of techni-
cal development. In the IPC technologies are hierarchically 
ordered in accordance to the degree of generality. 
This search does not attempt to cover what is understood 
by biotechnology at the  conceptual point of view. Instead 
it  aims to be a cutting from the representative areas of 
the biotechnology sector. For instance, Santos (2010) pro-
poses 15 different classifications for biotechnology, while the 
present survey proposes only three. However, the classifica-
tions proposed by the author cover a broad spectrum, com-
prehending new plant varieties and health, bioremediation, 
enzymes, even equipment. 
For the search of this article we considered that new plant 
varieties obtained by traditional breeding are not part of 
modern biotechnology. If the new variety is obtained by ge-
netic engineering, then it will receive the C12N15 classifica-
tion and it will be detected by the classification proposed 
here. Another example, if a new strain of yeast for alcoholic 
fermentation is developed, this patent applications will also 
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patent applications are low, this makes a signifi cant differ-
ence. Thereby the corrected fi gures were the one that were 
used by this search. Graphs 1 shows the number of patent 
applications per year along the decade. Note a growth trend 
line caused mainly by the large number of applications in the 
years 2007 and 2008.    
It is possible to conduct an analysis of the content of the 
patent application fi led in biotechnology in the classifi cations 
selected in order to know the technological fi elds that are 
being searched by Brazilian inventors. So far it is likely to 
identify “genetic engineering” as the most of patent applica-
tions. 
Patent Applicants’ Profi le
In order to classify the various types of patent applicants 
and their respective profi les, it was adopted fi ve categories:
a) Universities: this category comprises higher education 
institutions, buy their own or in partnership. They develop 
scientifi c research, and may be public or private entities This 
survey focus in this patent applicant category;
b) Individuals: they are researchers or inventors who con-
duct patent fi ling as individuals, and this category may com-
prise only one individual or a group of researchers;
c) Research Centers: they are mostly public. The exception 
is Brazilian Petroleum Company (Petrobrás). This company 
has a management model similar to public research centers 
as: Brazilian Agro Business Company (EMPRAPA); Brazilian 
Nuclear Energy Commission (CNEN); Brazilian National 
Council for Research (CNPq),  Butantan Institute, and Os-
waldo Cruz Foundation (FIOCRUZ);
to 2010 in the Espacenet Patent Database for the classifi ca-
tions adopted (C12N, C07K14, and C0721/04) indicates a 
total of 396 patent applications over the past 10 years, as 
shown in Table 1. 
The fi gures should be correct to eliminate errors, i.e., re-
move cases of non-residents (patent applications that are 
not from Brazil); of patent applications in previous years; 
and duplicated document. This happens because the patent 
publication may be incomplete, and Espacenet is unable to 
identify the applications properly. The corrected fi gures is 
30% less then the total shown by Espacenet. As Brazilian 
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The amount of 31 Brazilian universities that have already 
filed patents in biotechnology in Brazil in the last decade are 
identified in Table 3. The five universities that have mostly 
filed were: São Paulo University (USP) with 35 patent ap-
plications, Minas Gerais University (UFMG) with 28, Campi-
nas University (Unicamp) with 20, Rio de Janeiro University 
(UFRJ) with 19, and Brasilia University (UnB) with 11, sum-
ming up 113 patent applications. Noted that of 191 patent 
applications filed by universities in 10 years, 59% were filed 
by these five universities.
d) Private firms: in this category were included only private 
companies, as isolated applicants without partnership;
e) Partnerships: this category was created to identify part-
nerships between public institutions and private firms, nota-
bly with universities, considering what Brazilian innovation 
law advocates. Although there are others forms of partner-
ship between universities and private firms, such as consult-
ing, spin-offs, and others agreements. In this article it is used 
the co-entitlement in patent applications as partnerships.
The largest patent applicant in Biotechnology are the univer-
sities, with 193 files in 10 years, followed by individuals with 
78 files, research centers with 59, private firms with 44, and 
partnerships with 23, according to Table 2.
Although the universities hold 48% of the patent applica-
tions in Biotechnology, as indicated in Graph 2, it is worth 
noting that the number of applications by private firms is 
not so low when compared with public research centres, i.e. 
11% and 15% of the total, respectively.
Since 2005 the number of patent applications filed by uni-
versities has been growing. This growth can be explained by 
implication of Innovation Law and also by INPI performance 
in the training of  researchers of the Brazilian universities, 
and managers in charge of the Centers for Technological In-
novation (NITs), established by the Innovation Law.
Table 2: Brazilian Patent Applications  in Representative Sectors of Biotechnology by patent applicants’ profile – 2000 to 2010.
Year Universities Individuals Public Research Centers Private Firms Partnerships Total
2000 7 8 10 5 1 31
2001 7 6 0 1 0 14
2002 8 5 6 2 0 21
2003 12 11 4 1 1 29
2004 17 4 4 7 4 36
2005 20 7 4 1 2 34
2006 21 8 5 2 1 37
2007 33 15 9 9 4 70
2008 27 10 5 8 5 55
2009 18 3 9 4 3 37
2010 23 1 2 4 2 32
total 193 78 58 44 23 396
Graph 2: Brazilian Patent Applications distribution by applicants’ 
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  2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 total
1
USP (São Paulo Uni-
versity) 2   7 2 5 3 4 6 2 4 35
2
UFMG (Minas Gerais 
University) 1 2 2  1 1 1 9 6 2 3 28
3
UNICAMP (Campinas 
University) 2 1 2 1 2 4  2 1 3 2 20
4
UFRJ (Rio de Janeiro 
University)  1  1 4 1 3 5 2  2 19
5
UnB (Brasilia Univer-
sity)  1  1  2 2 3 2   11
6
UFRGS (Rio Grande 
do Sul University) 1    3     4 2 10
7
UNESP (São Paulo 
Estadual University)  1 2 1  1  1 1  1 8
8
UCS (Caxias do Sul 
University)       1 3 3 1  8
9
UFV (Viçosa Univer-
sity) 1     1 1 1   2 6
10
UNIFESP (São Paulo  




sity)  1  1 2  1     5
12
UFsCAR ( São 
Carlos/ São Paulo 
University)   1    1 2  1  5
13
UFPR ( Paraná Uni-




sity)     1     1 2 4
15
PUC (Católica do 
Rio Grande do Sul 
University)      1  1 1   3
16
UFPEL (Pelotas/ Rio 
Grande do Sul Uni-
versity)     1  1     2
17
UENF (Norte Flumin-
ense Estadual do Rio 
de Janeiro University))      1    1  2
18
UFSC ( Santa Catari-
na University)         1 1  2
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19
PUC (Católica do Rio 
de Janeiro University)         1   1
20
FMO (Mokiti Okada 
University)      1      1
21
UFFRJ (Federal Flu-
minense University)      1      1
22
UEPA (Pará Estadual 
University)      1      1
23
UCB (Católica de 
Brasília University)       1     1
24
UEM (Maringá/ 
Paraná University)       1     1
25
UEL (Londrina/ 
Paraná University)       1     1
26
UMC (Mogi das 
Cruzes/ São Paulo 
University)         1   1
27
UFTM/ (Triângulo 
Mineiro/ Minas Gerais 
University)          1  1
28
UFGO ( Goiás Univer-
sity)          1  1
29
UFLA (Lavras / Minas 
Gerais University)           1 1
30
UFAM (Amazonas 
University)           1 1
31
UFSM (Santa Maria/ 
Rio Grande do Sul 
University)           1 1
Table 3: Number of Annual Brazilian Patent Applications by Brazilian Universities in representative sectors of  
Biotechnology – 2000 to 2010.
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Partnerships in Patent Applications 
There are only two private firms which have more than one 
patent application in partnerships with universities – Biolab 
Sanus and Farmarcor Biotec, but none of them have more 
than two patent application each one.
On the other hand, it can be observed in Figure 2 that the 
partnerships between universities and private firms are 
still not significant. In the last 10 years, of the total of 23 
partnerships in patent applications between public insti-
tutions and private firms, 13 were with Brazilian universi-
ties, 4 with São Paulo University, and 4 with Brasilia Uni-
versity. All of then with different private firms. In addition, 
12 partnerships were established since the entry into force 
of Innovation Law in 2005.
Figure 2: Partnerships in patent  applications from 2000 to 2010
Partnerships in Patent Applications 
Year Public research center Universities Private firms
2000
Brazilian Agrobusiness 
Company (EMBRAPA) VALEE S.A.
2003
Research Founda-
tion of Minas Gerais 
(FAPEMIG) BIOGENETICS
2004
Brazilian Nuclear Energy 
Commission (CNEN) HORMOGEN
2004
Research Foundation of 
São Paulo (FAPESP) BIOLAB SANUS
2004
Research Foundation of 
São Paulo (FAPESP) BIOSINTÉTICA LTDA
2004 UNIFESP UNIÃO QUÍMICA
2005 BUTANTAN Institute BIOLAB SANUS
2005 UNIVERSIDADE DE BRASILIA POLI ENGENHARIA
2006
Research Foundation of 
São Paulo (FAPESP) CRISTÁLIA
2007 UNIVERSIDADE DE SÃO PAULO FARMARCOR BIOTEC
2007 UNIVERSIDADE DE SÃO PAULO FARMARCOR BIOTEC
2007 CAIXIAS DO SUL BIOENZIMA
2007 UNIVERSIDADE DE SÃO PAULO BIOVEGETAL
2008 UNIVERSIDADE DE BRASILIA OURO FINO
2008 SENAI BIOTECNOLOGIA S.A.
2008 UNICAMP BLAUSIGEL
2008 UNIVERSIDADE DE BRASILIA COALHOS BIO PARAN
2008 UBERLÂNDIA IMUNOSCAN MOLECULAR
2009 SANTA CATARINA MEDIC FORMULA
2009 UNIVERSIDADE DE BRASILIA UNICÓRNIO REPROD. ANIMAL
2009 BUTANTAN Institute HOSPITAL ALEMÃO
2010
Oswaldo Cruz Founda-
tion (FIOCRUZ) ALVOS CONSULT. PROD. BIOTEC
2010 UNIVERSIDADE DE SÃO PAULO INVENT. BIOTEC
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Final Remarks
The handling of the compiled information will enable the 
development of an insertion mapping of the IP topic in 
postgraduate courses in biotechnology and Brazilian uni-
versities. Later it will be possible to make a comparative 
analysis with data from other countries. But it is worth not-
ing that the patent applications in the USA and China, for 
example, have already reached the thousands by year. While 
in Brazil the amount of residents patent applications in rep-
resentatives sectors of Biotechnology does not reach 400 
applications in 10 years.
It will also be possible to conduct an analysis of the con-
tent of the patents filed in Biotechnology aiming the iden-
tification of the technological fields that are being investi-
gated by Brazilian inventors. Beforehand, we can identify 
genetic engineering as the field that assembles the majority 
of patent applications.
Among the different patent applicants profile, two groups 
draw attention, “universities” that had a significant growth 
over the decade, and “inventors” with a clear decrease com-
pared to the beginning of the last decade. These outcomes 
are interesting, mainly if one takes into account that Brazilian 
universities has been increasing more and more their re-
search capacity, which could mean better patents, technical-
ly. However the two groups mentioned, do not act directly 
in the market, depending on the transfer of technology to 
firms that actually have access to the market.
Another aspect to point out is that since 2005 the num-
ber of patent applications filed by universities has been 
growing. This growth can be explained by the implemen-
tation of the Innovation Law and also by the INPI perfor-
mance in the process of the managers’ training and the 
dissemination of  Intellectual Property culture, beyond 
others institutional aspects.
Further studies of the compiled data, and more research 
on scientific publication, and also in the academic IP teach-
ing will enable depth analysis, that may help clarify the gap 
between scientific production and innovation in the bio-
technology academic environment. It will also allow a better 
understanding of the global context where the national and 
international debate on the topics of IP and biotechnology 
is inserted, and provide elements on how to adjust to this 
context to respond for a emerging IP agenda, that can assist 
in public policies formulation  in this field.
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